Trial Profile
Endometrial receptivity with different support protocols for the luteal phase in ovarian stimulation cycles in which final oocyte maturation is carried out with GnRH analogues. Analysis by endometrial microarrays.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Estradiol valerate (Primary) ; Lutropin alfa (Primary) ; Progesterone (Primary) ; Triptorelin (Primary) ; Chorionic gonadotropin
- Indications Ovarian hyperstimulation syndrome
- Focus Therapeutic Use
- Acronyms ERAMAD
- 25 Oct 2016 Status changed from recruiting to completed.
- 22 Feb 2012 Additional lead trial centres added as reported by European Clinical Trials Database.
- 22 Feb 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2011-003250-34).